Jefferies Reaffirms Their Buy Rating on Mankind Pharma Ltd. (MANKIND)
Jefferies analyst Alok Dalal maintained a Buy rating on Mankind Pharma Ltd. (MANKIND – Research Report) on May 23 and set a price target of INR2,870.00. The company's shares closed last Friday at INR2,425.00.
Confident Investing Starts Here:
According to TipRanks, Dalal is ranked #4967 out of 9536 analysts.
In addition to Jefferies, Mankind Pharma Ltd. also received a Buy from J.P. Morgan's Bansi Desai in a report issued on May 21. However, on the same day, Bank of America Securities maintained a Sell rating on Mankind Pharma Ltd. (NSE: MANKIND).
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
17 minutes ago
- Business Insider
Scentre Group (STGPF) was upgraded to a Hold Rating at Macquarie
In a report released today, from Macquarie upgraded Scentre Group (STGPF – Research Report) to a Hold, with a price target of A$3.24. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Scentre Group has an analyst consensus of Strong Buy, with a price target consensus of $2.51. The company has a one-year high of $3.09 and a one-year low of $1.59. Currently, Scentre Group has an average volume of 9,213.
Business Insider
17 minutes ago
- Business Insider
Centuria Capital Group (CNI) was upgraded to a Buy Rating at Macquarie
Centuria Capital Group (CNI – Research Report) received a Buy rating and a A$1.78 price target from Macquarie analyst today. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter The word on The Street in general, suggests a Moderate Sell analyst consensus rating for Centuria Capital Group with a A$1.82 average price target. Based on Centuria Capital Group's latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of A$229.42 million and a GAAP net loss of A$518 thousand. In comparison, last year the company earned a revenue of A$136.06 million and had a net profit of A$45.21 million
Business Insider
an hour ago
- Business Insider
Morgan Stanley Remains a Buy on Prestige Estates Projects Limited (PRESTIGE)
Morgan Stanley analyst Praveen Choudhary maintained a Buy rating on Prestige Estates Projects Limited (PRESTIGE – Research Report) on May 30 and set a price target of INR1,700.00. The company's shares closed last Friday at INR1,484.00. Confident Investing Starts Here: According to TipRanks, Choudhary is a 3-star analyst with an average return of 1.8% and a 49.15% success rate. Choudhary covers the Consumer Cyclical sector, focusing on stocks such as Melco Resorts & Entertainment, Galaxy Entertainment Group, and Wynn Macau. Currently, the analyst consensus on Prestige Estates Projects Limited is a Moderate Buy with an average price target of INR1,825.00, implying a 22.98% upside from current levels. In a report released on May 31, Jefferies also maintained a Buy rating on the stock with a INR1,700.00 price target. Based on Prestige Estates Projects Limited's latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of INR20.25 billion and a net profit of INR2.33 billion. In comparison, last year the company earned a revenue of INR16.81 billion and had a net profit of INR2.67 billion
